EY Announces Rami Elghandour, President and CEO of Nevro, as 2017 Entrepreneur Of The Year®
REDWOOD CITY, Calif., June 28, 2017 /PRNewswire/ -- Nevro Corp., a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that EY recognized Rami Elghandour, President and CEO of Nevro, with the Entrepreneur Of The Year® 2017 Award in Northern California. The award recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. Mr. Elghandour was selected by an independent panel of judges, and the award was presented at a special gala event at the Fairmont San Jose on June 23, 2017.
"I am honored to accept the EY Entrepreneur Of The Year Award for Northern California on behalf of the Nevro team," said Mr. Elghandour. "This award is truly a reflection of our amazing people, our culture, and the impact our team has on helping patients regain their independence from the crippling effects of chronic pain. Chronic pain has increasingly become a part of our national dialogue and we are proud to offer a non-surgical, non-opioid solution to help address this health challenge. We are committed to continuing to invest in innovative, evidence-based therapies to help many more patients in need."
Mr. Elghandour joined Nevro in 2012 and currently serves as President and CEO of the company. During Mr. Elghandour's tenure, Nevro grew from a small startup to a leader in neuromodulation, going public in 2014 and growing from 65 to over 650 people in under five years. In 2016, Nevro achieved worldwide revenue of $228.5 million, an increase of 228% as reported over the prior year, and has been recognized as one of the leading companies in Silicon Valley by The Mercury News' SV150 list.
Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system to treat patients suffering from chronic pain. Over 25 million adults in the United States suffer from chronic pain according to the National Center for Health Statistics and the annual economic cost of this population has been estimated at nearly $635 billion. The Senza system is a non-surgical, non-opioid treatment option for patients suffering from chronic back and leg pain and is commercially available in Europe, Australia, and the United States. The Senza system delivers Nevro's innovative HF10 therapy which is nearly twice as efficacious as existing SCS therapies and was demonstrated as clinically superior in the groundbreaking SENZA-RCT clinical trial, the largest prospective randomized SCS study to assess the treatment of chronic back and leg pain.
About Entrepreneur Of The Year®
Entrepreneur Of The Year®, founded by EY, is the world's most prestigious business awards program for entrepreneurs, chosen from an independent panel of judges including entrepreneurs and prominent leaders from business, finance, and the local community. The program makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global awards program of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 145 cities in more than 60 countries. ey.com/eoy
About EY
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities. EY refers to the global organization, and may refer to one or more of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.
About Nevro
Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. Senza, HF10, Nevro and the Nevro logo are trademarks of Nevro.
Investor Relations Contact:
Nevro Investor Relations
Katherine Bock
(650) 433-3247
[email protected]
SOURCE Nevro Corp.
SOURCE Nevro Corp.
Share this article